SANUWAVE Health, Inc. Common Stock (SNWV) - Net Assets
Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has net assets worth $1.84 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($37.10 Million) and total liabilities ($35.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SANUWAVE Health, Inc. Common Stock tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.84 Million |
| % of Total Assets | 4.95% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SANUWAVE Health, Inc. Common Stock - Net Assets Trend (2006–2025)
This chart illustrates how SANUWAVE Health, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. See SANUWAVE Health, Inc. Common Stock liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for SANUWAVE Health, Inc. Common Stock (2006–2025)
The table below shows the annual net assets of SANUWAVE Health, Inc. Common Stock from 2006 to 2025. For live valuation and market cap data, see market cap of SANUWAVE Health, Inc. Common Stock.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.62 Million | +112.73% |
| 2024-12-31 | $-12.72 Million | +70.55% |
| 2023-12-31 | $-43.18 Million | -5.29% |
| 2022-12-31 | $-41.01 Million | -5.27% |
| 2021-12-31 | $-38.96 Million | -183.97% |
| 2020-12-31 | $-13.72 Million | -36.32% |
| 2019-12-31 | $-10.06 Million | +34.47% |
| 2018-12-31 | $-15.36 Million | -55.41% |
| 2017-12-31 | $-9.88 Million | -42.96% |
| 2016-12-31 | $-6.91 Million | -17.59% |
| 2015-12-31 | $-5.88 Million | -278.87% |
| 2014-12-31 | $-1.55 Million | +74.68% |
| 2013-12-31 | $-6.13 Million | +6.00% |
| 2012-12-31 | $-6.52 Million | -324.28% |
| 2011-12-31 | $-1.54 Million | +85.39% |
| 2010-12-31 | $-10.52 Million | -78.72% |
| 2009-12-31 | $-5.88 Million | -7963.91% |
| 2008-12-31 | $-72.97K | -57.19% |
| 2007-12-31 | $-46.42K | -332.67% |
| 2006-12-31 | $-10.73K | -- |
Equity Component Analysis
This analysis shows how different components contribute to SANUWAVE Health, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 611736.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $9.00K | 0.56% |
| Other Comprehensive Income | $10.00K | 0.62% |
| Other Components | $244.28 Million | 15088.63% |
| Total Equity | $1.62 Million | 100.00% |
SANUWAVE Health, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Koryo Electronics Co Ltd
TWO:8032
|
$78.19 Million |
|
LBG MEDIA PLC LS -001
F:S83
|
$78.22 Million |
|
Dallasnews Corp
NASDAQ:DALN
|
$78.24 Million |
|
Vasta Platform Ltd
NASDAQ:VSTA
|
$78.25 Million |
|
FIH Mobile Limited
F:FW3
|
$78.16 Million |
|
Ekopak BV
BR:EKOP
|
$78.15 Million |
|
Spark I Acquisition Corp. Class A Ordinary Share
NASDAQ:SPKL
|
$78.15 Million |
|
Cnergenz Bhd
KLSE:0246
|
$78.14 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SANUWAVE Health, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -12,717,000 to 1,619,000, a change of 14,336,000.
- Net income of 11,813,000 contributed positively to equity growth.
- Other factors increased equity by 2,523,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $11.81 Million | +729.65% |
| Other Changes | $2.52 Million | +155.84% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares SANUWAVE Health, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 50.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | $0.00 | $9.09 | x |
| 2007-12-31 | $0.00 | $9.09 | x |
| 2008-12-31 | $-0.01 | $9.09 | x |
| 2009-12-31 | $-0.52 | $9.09 | x |
| 2010-12-31 | $-0.81 | $9.09 | x |
| 2011-12-31 | $-0.08 | $9.09 | x |
| 2012-12-31 | $-0.31 | $9.09 | x |
| 2013-12-31 | $-0.22 | $9.09 | x |
| 2014-12-31 | $-0.03 | $9.09 | x |
| 2015-12-31 | $-0.09 | $9.09 | x |
| 2016-12-31 | $-0.06 | $9.09 | x |
| 2017-12-31 | $-0.07 | $9.09 | x |
| 2018-12-31 | $-0.10 | $9.09 | x |
| 2019-12-31 | $-0.05 | $9.09 | x |
| 2020-12-31 | $-0.03 | $9.09 | x |
| 2021-12-31 | $-0.08 | $9.09 | x |
| 2022-12-31 | $-0.07 | $9.09 | x |
| 2023-12-31 | $-0.05 | $9.09 | x |
| 2024-12-31 | $-2.85 | $9.09 | x |
| 2025-12-31 | $0.18 | $9.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SANUWAVE Health, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 729.65%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 26.82%
- • Asset Turnover: 1.18x
- • Equity Multiplier: 23.07x
- Recent ROE (729.65%) is above the historical average (36.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $23.06K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-31.05K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.25K |
| 2009 | 0.00% | -931.26% | 0.11x | 0.00x | $-5.56 Million |
| 2010 | 0.00% | -2048.53% | 0.24x | 0.00x | $-13.87 Million |
| 2011 | 0.00% | -1275.75% | 0.13x | 0.00x | $-10.09 Million |
| 2012 | 0.00% | -832.21% | 0.42x | 0.00x | $-5.75 Million |
| 2013 | 0.00% | -1412.41% | 0.50x | 0.00x | $-10.69 Million |
| 2014 | 0.00% | -705.02% | 0.18x | 0.00x | $-5.82 Million |
| 2015 | 0.00% | -498.22% | 1.01x | 0.00x | $-4.22 Million |
| 2016 | 0.00% | -467.93% | 1.37x | 0.00x | $-5.75 Million |
| 2017 | 0.00% | -749.86% | 0.58x | 0.00x | $-4.55 Million |
| 2018 | 0.00% | -628.70% | 1.57x | 0.00x | $-10.10 Million |
| 2019 | 0.00% | -1013.86% | 0.30x | 0.00x | $-9.42 Million |
| 2020 | 0.00% | -762.47% | 0.18x | 0.00x | $-29.57 Million |
| 2021 | 0.00% | -209.52% | 0.70x | 0.00x | $-23.36 Million |
| 2022 | 0.00% | -61.48% | 0.84x | 0.00x | $-6.19 Million |
| 2023 | 0.00% | -126.52% | 0.91x | 0.00x | $-21.49 Million |
| 2024 | 0.00% | -96.13% | 1.08x | 0.00x | $-30.10 Million |
| 2025 | 729.65% | 26.82% | 1.18x | 23.07x | $11.65 Million |
Industry Comparison
This section compares SANUWAVE Health, Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,818,520,110
- Average return on equity (ROE) among peers: -48.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SANUWAVE Health, Inc. Common Stock (SNWV) | $1.84 Million | 0.00% | 19.18x | $78.16 Million |
| Abbott Laboratories (ABT) | $17.78 Billion | 20.28% | 1.23x | $153.89 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $15.55 Million |
| Aethlon Medical Inc (AEMD) | $-5.98 Million | 0.00% | 0.00x | $2.51 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $1.29 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $6.89 Million | 30.07% | 0.49x | $6.67 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $7.70 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $8.10 Million | -140.88% | 0.21x | $4.44 Million |
| Artivion Inc (AORT) | $17.90 Million | 7.26% | 0.20x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $22.89 Million | 2.69% | 0.23x | $176.29 Million |
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more